TrialCancer chemotherapy and pharmacology2014

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.

Toru Aoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.